Frank Wunder

4.7k total citations · 1 hit paper
50 papers, 3.5k citations indexed

About

Frank Wunder is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Frank Wunder has authored 50 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Frank Wunder's work include Nitric Oxide and Endothelin Effects (13 papers), Receptor Mechanisms and Signaling (12 papers) and Phosphodiesterase function and regulation (10 papers). Frank Wunder is often cited by papers focused on Nitric Oxide and Endothelin Effects (13 papers), Receptor Mechanisms and Signaling (12 papers) and Phosphodiesterase function and regulation (10 papers). Frank Wunder collaborates with scholars based in Germany, United States and United Kingdom. Frank Wunder's co-authors include Olaf Pongs, Jens Rettig, Stefan H. Heinemann, Christoph Lorra, J. Oliver Dolly, David N. Parcej, Ralf Lichtinghagen, Wilfried A. Kues, H. Schröder and Isabella M. Grumbach and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Frank Wunder

47 papers receiving 3.5k citations

Hit Papers

Inactivation properties of voltage-gated K+ channels alte... 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Wunder Germany 25 2.6k 1.5k 1.1k 634 199 50 3.5k
Mark S. Shapiro United States 40 3.7k 1.4× 2.3k 1.6× 1.4k 1.2× 440 0.7× 212 1.1× 100 4.8k
Ligia Toro United States 42 4.6k 1.8× 2.2k 1.5× 2.4k 2.1× 713 1.1× 92 0.5× 91 5.9k
Jean Mironneau France 43 3.5k 1.4× 1.6k 1.1× 1.5k 1.3× 951 1.5× 76 0.4× 141 4.5k
Andy Hudmon United States 32 2.9k 1.2× 1.8k 1.2× 780 0.7× 558 0.9× 67 0.3× 66 4.0k
Trevor J. Hallam United Kingdom 34 3.5k 1.4× 1.1k 0.8× 704 0.6× 1.2k 1.8× 74 0.4× 70 5.7k
Palle Christophersen Denmark 37 2.8k 1.1× 1.6k 1.1× 991 0.9× 684 1.1× 31 0.2× 83 3.7k
Andrew P. Braun Canada 28 2.2k 0.9× 931 0.6× 1.2k 1.1× 618 1.0× 34 0.2× 86 3.0k
Don‐On Daniel Mak United States 31 2.9k 1.1× 971 0.7× 379 0.3× 687 1.1× 61 0.3× 46 3.9k
Martyn P. Mahaut‐Smith United Kingdom 37 2.3k 0.9× 1.0k 0.7× 1.1k 0.9× 401 0.6× 32 0.2× 106 3.9k
Rameshwar K. Sharma United States 37 2.7k 1.1× 1.4k 0.9× 682 0.6× 612 1.0× 50 0.3× 148 3.8k

Countries citing papers authored by Frank Wunder

Since Specialization
Citations

This map shows the geographic impact of Frank Wunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Wunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Wunder more than expected).

Fields of papers citing papers by Frank Wunder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Wunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Wunder. The network helps show where Frank Wunder may publish in the future.

Co-authorship network of co-authors of Frank Wunder

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Wunder. A scholar is included among the top collaborators of Frank Wunder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Wunder. Frank Wunder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hahn, Michael G., Martina Delbeck, Lisa Dietz, et al.. (2022). Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC. Respiratory Research. 23(1). 272–272. 10 indexed citations
2.
Meibom, Daniel, André P. Dieskau, Frank Eitner, et al.. (2022). BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of Medicinal Chemistry. 65(24). 16420–16431. 7 indexed citations
3.
Sager, Hendrik B., Jana Wobst, Tan An Dang, et al.. (2022). Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation. Nature Cardiovascular Research. 1(12). 1174–1186. 20 indexed citations
4.
Grundmann, Manuel, et al.. (2021). Establishment of a novel, cell-based autotaxin assay. Analytical Biochemistry. 630. 114322–114322. 1 indexed citations
5.
Yeh, Chen-Min, et al.. (2014). Engineering of a red-light–activated human cAMP/cGMP-specific phosphodiesterase. Proceedings of the National Academy of Sciences. 111(24). 8803–8808. 133 indexed citations
6.
Egbert, Jeremy R., Leia C. Shuhaibar, Jerid W. Robinson, et al.. (2014). Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes. Development. 141(18). 3594–3604. 84 indexed citations
7.
Robinson, Jerid W., Meijia Zhang, Leia C. Shuhaibar, et al.. (2012). Luteinizing hormone reduces the activity of the NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP decrease that promotes resumption of meiosis in oocytes. Developmental Biology. 366(2). 308–316. 111 indexed citations
8.
Wunder, Frank, et al.. (2012). Pharmacological characterization of receptor guanylyl cyclase reporter cell lines. European Journal of Pharmacology. 698(1-3). 131–136. 3 indexed citations
9.
Hirth‐Dietrich, Claudia, Cristina Alonso‐Alija, Michael Härter, et al.. (2011). Nitric Oxide-independent Activation of Soluble Guanylate Cyclase by BAY 60-2770 in Experimental Liver Fibrosis. Arzneimittelforschung. 58(2). 71–80. 70 indexed citations
10.
Durrant, Jacob D., Rommie E. Amaro, Lei Xie, et al.. (2010). A Multidimensional Strategy to Detect Polypharmacological Targets in the Absence of Structural and Sequence Homology. PLoS Computational Biology. 6(1). e1000648–e1000648. 64 indexed citations
11.
Mittendorf, Joachim, Stefan Weigand, Cristina Alonso‐Alija, et al.. (2009). Discovery of Riociguat (BAY 63‐2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension. ChemMedChem. 4(5). 853–865. 145 indexed citations
12.
Wunder, Frank, et al.. (2008). Pharmacological and Kinetic Characterization of Adrenomedullin 1 and Calcitonin Gene-Related Peptide 1 Receptor Reporter Cell Lines. Molecular Pharmacology. 73(4). 1235–1243. 23 indexed citations
13.
Wunder, Frank, et al.. (2008). Functional Cell-Based Assays in Microliter Volumes for Ultra-High Throughput Screening. Combinatorial Chemistry & High Throughput Screening. 11(7). 495–504. 18 indexed citations
14.
Wunder, Frank, et al.. (2005). Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line. Molecular Pharmacology. 68(6). 1775–1781. 101 indexed citations
15.
Stasch, Johannes‐Peter, Péter Schmidt, Cristina Alonso‐Alija, et al.. (2002). NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. British Journal of Pharmacology. 136(5). 773–783. 251 indexed citations
16.
Becker, Eva Maria, Frank Wunder, Raimund Kast, et al.. (1999). Generation and Characterization of a Stable Soluble Guanylate Cyclase-Overexpressing CHO Cell Line. Nitric Oxide. 3(1). 55–66. 19 indexed citations
17.
Schwarzer, Christoph, Andreas Eberhart, Hartmut Glossmann, et al.. (1996). Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. Journal of Neuroscience. 16(3). 955–963. 274 indexed citations
18.
Heinemann, Stefan H., Jens Rettig, Frank Wunder, & Olaf Pongs. (1995). Molecular and functional characterization of a rat brain Kvβ3 potassium channel subunit. FEBS Letters. 377(3). 383–389. 91 indexed citations
19.
Rettig, Jens, Frank Wunder, Martin Stocker, et al.. (1992). Characterization of a Shaw-related potassium channel family in rat brain.. The EMBO Journal. 11(7). 2473–2486. 174 indexed citations
20.
Kues, Wilfried A. & Frank Wunder. (1992). Heterogeneous Expression Patterns of Mammalian Potassium Channel Genes in Developing and Adult Rat Brain. European Journal of Neuroscience. 4(12). 1296–1308. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026